Open Access

Closing/Conclusion - What have we learned from SGLT-2 inhibitors in heart failure?

Presentation

About the speaker

Professor Seok Min Kang

Yonsei University Medical College, Seoul (Korea (Republic of))
4 presentations
0 follower

3 more presentations in this session

Welcome/Opening - What have we learned from SGLT-2 inhibitors in heart failure?

Speaker: Professor S. Kang (Seoul, KR)

Thumbnail

What have we learned from SGLT-2 Inhibitors in Heart Failure?

Speaker: Professor R. Fontes Carvalho (Vila Nova de Gaia, PT)

Thumbnail

Q&A - What have we learned from SGLT-2 inhibitors in heart failure?

Speaker: Professor S. Kang (Seoul, KR) Professor R. Fontes Carvalho (Vila Nova de Gaia, PT)

Thumbnail

Access the full session

What have we learned from SGLT-2 inhibitors in heart failure?

Speakers: Professor S. Kang, Professor S. Kang, Professor R. Fontes Carvalho, Professor S. Kang, Professor R. Fontes Carvalho
Thumbnail

About the event

Image

ESC Asia with APSC & AFC 2020

3 December - 5 December 2020

Sessions Presentations

Related content

ESC Premium Access

Virtual heart.

23 October 2021

ESC Premium Access

EMPEROR-Pooled: effect of empagliflozin on serious adverse renal outcomes in chronic heart failure – a prospective alpha-protected, Individual patient-level pooled analysis

27 August 2021

ESC Premium Access

EMPEROR-Preserved - Discussant review.

27 August 2021

This platform is supported by

logo Novo Nordisk